Bupa stung by massive impairment charges

Bupa has blamed the massive health reforms taking place in its key UK and US markets, together with continued weak economies in both countries, for a 72% slump in pre-tax surplus.Underlying growth remained strong in 2010, with revenues and pre-tax surplus before non-recurring items up 9% to £7.5bn and £464.9m respectively. But pre-tax surplus was…